The details bedevil DCOR
- PMID: 17943149
- DOI: 10.1038/sj.ki.5002527
The details bedevil DCOR
Abstract
Calcium-free oral phosphorus binders were heralded as a striking new development for patients with chronic kidney disease, promising a reduction in morbidity and mortality from cardiovascular disease. Sevelamer hydrochloride was the first such drug introduced to the market. Dialysis Clinical Outcomes Revisited (DCOR) is an outcomes study on the effect of sevelamer compared with calcium-based phosphorus binders in dialysis patients. It does not show a clear superiority of one compound over the other.
Comment on
-
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients.Kidney Int. 2007 Nov;72(9):1130-7. doi: 10.1038/sj.ki.5002466. Epub 2007 Aug 29. Kidney Int. 2007. PMID: 17728707 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical